FOXA1 overexpression in patients with PCa is inversely correlated with NFI signaling activity and with the expression of the genes that regulate the presentation of antigens, contributing to the resistance to immune checkpoint inhibitors [92,93]. Here, FOXA1 is linked to posterior cortical atrophy.